The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.
1 day ago
2
Biology Evolution
Biology Molecular & Computational biology
The GIST
Editors' notes
Neanderthal gene variant lowers muscle enzyme activity in modern humans
by Max Planck Society
edited by Lisa Lock, reviewed by Andrew Zinin
Neanderthal
Credit: Pixabay/CC0 Public Domain
The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.
In a study published in Nature Communications, researchers compared ancient Neanderthal DNA with modern human genomes and found that all Neanderthals carried a specific AMPD1 variant absent in other species. Laboratory-produced enzymes with this variant showed a 25% reduction in AMPD1 activity. When introduced into genetically engineered mice, the reduction reached 80% in muscle tissue, impairing enzyme function.
The study also revealed that modern humans inherited this variant through interbreeding with Neanderthals, who inhabited Europe and Western Asia before encountering modern humans about 50,000 years ago. Today, individuals of non-African descent carry roughly 1% to 2% Neanderthal DNA.
The Neanderthal AMPD1 variant is carried by 2% to 8% of Europeans today, suggesting that it is generally tolerated.
Strikingly, most individuals who carry the variant do not experience significant health issues. However, the enzyme appears to play an important role in athletic performance," explains Dominik Macak, the study's first author. An analysis of more than 1,000 elite athletes across various sports revealed that individuals who carry a non-functional AMPD1 are less likely to become top-level athletes.
1 day ago
2
Biology Evolution
Biology Molecular & Computational biology
The GIST
Editors' notes
Neanderthal gene variant lowers muscle enzyme activity in modern humans
by Max Planck Society
edited by Lisa Lock, reviewed by Andrew Zinin
Neanderthal
Credit: Pixabay/CC0 Public Domain
The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.
In a study published in Nature Communications, researchers compared ancient Neanderthal DNA with modern human genomes and found that all Neanderthals carried a specific AMPD1 variant absent in other species. Laboratory-produced enzymes with this variant showed a 25% reduction in AMPD1 activity. When introduced into genetically engineered mice, the reduction reached 80% in muscle tissue, impairing enzyme function.
The study also revealed that modern humans inherited this variant through interbreeding with Neanderthals, who inhabited Europe and Western Asia before encountering modern humans about 50,000 years ago. Today, individuals of non-African descent carry roughly 1% to 2% Neanderthal DNA.
The Neanderthal AMPD1 variant is carried by 2% to 8% of Europeans today, suggesting that it is generally tolerated.
Neanderthal variant reduces activity of a key muscle enzyme
Amino acid differences between modern humans and Neandertals in enzymes involved in purine metabolism. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-61605-4
"Strikingly, most individuals who carry the variant do not experience significant health issues. However, the enzyme appears to play an important role in athletic performance," explains Dominik Macak, the study's first author. An analysis of more than 1,000 elite athletes across various sports revealed that individuals who carry a non-functional AMPD1 are less likely to become top-level athletes.
Get free science updates with Science X Daily and Weekly Newsletters — subscribe now to customize your preferences!
"Carrying a broken AMPD1 enzyme, the likelihood of reaching athletic performance is reduced by half," Macak adds.
In summary, although AMPD1 activity appears to have only moderate relevance in contemporary Western societies, it is important under extreme physical conditions, such as those experienced by athletes. The researchers emphasize the importance of studying genetic variants in their physiological and evolutionary contexts in order to understand their biological effects.
"It's possible that cultural and technological advances in both modern humans and Neanderthals reduced the need for extreme muscle performance," says senior author Hugo Zeberg.
Understanding how ancient gene variants affect human physiology today can provide valuable insights into health, performance, and genetic diversity.
1 day ago
2
Biology Evolution
Biology Molecular & Computational biology
The GIST
Editors' notes
Neanderthal gene variant lowers muscle enzyme activity in modern humans
by Max Planck Society
edited by Lisa Lock, reviewed by Andrew Zinin
Neanderthal
Credit: Pixabay/CC0 Public Domain
The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.
In a study published in Nature Communications, researchers compared ancient Neanderthal DNA with modern human genomes and found that all Neanderthals carried a specific AMPD1 variant absent in other species. Laboratory-produced enzymes with this variant showed a 25% reduction in AMPD1 activity. When introduced into genetically engineered mice, the reduction reached 80% in muscle tissue, impairing enzyme function.
The study also revealed that modern humans inherited this variant through interbreeding with Neanderthals, who inhabited Europe and Western Asia before encountering modern humans about 50,000 years ago. Today, individuals of non-African descent carry roughly 1% to 2% Neanderthal DNA.
The Neanderthal AMPD1 variant is carried by 2% to 8% of Europeans today, suggesting that it is generally tolerated.
Strikingly, most individuals who carry the variant do not experience significant health issues. However, the enzyme appears to play an important role in athletic performance," explains Dominik Macak, the study's first author. An analysis of more than 1,000 elite athletes across various sports revealed that individuals who carry a non-functional AMPD1 are less likely to become top-level athletes.
1 day ago
2
Biology Evolution
Biology Molecular & Computational biology
The GIST
Editors' notes
Neanderthal gene variant lowers muscle enzyme activity in modern humans
by Max Planck Society
edited by Lisa Lock, reviewed by Andrew Zinin
Neanderthal
Credit: Pixabay/CC0 Public Domain
The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.
In a study published in Nature Communications, researchers compared ancient Neanderthal DNA with modern human genomes and found that all Neanderthals carried a specific AMPD1 variant absent in other species. Laboratory-produced enzymes with this variant showed a 25% reduction in AMPD1 activity. When introduced into genetically engineered mice, the reduction reached 80% in muscle tissue, impairing enzyme function.
The study also revealed that modern humans inherited this variant through interbreeding with Neanderthals, who inhabited Europe and Western Asia before encountering modern humans about 50,000 years ago. Today, individuals of non-African descent carry roughly 1% to 2% Neanderthal DNA.
The Neanderthal AMPD1 variant is carried by 2% to 8% of Europeans today, suggesting that it is generally tolerated.
Neanderthal variant reduces activity of a key muscle enzyme
Amino acid differences between modern humans and Neandertals in enzymes involved in purine metabolism. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-61605-4
"Strikingly, most individuals who carry the variant do not experience significant health issues. However, the enzyme appears to play an important role in athletic performance," explains Dominik Macak, the study's first author. An analysis of more than 1,000 elite athletes across various sports revealed that individuals who carry a non-functional AMPD1 are less likely to become top-level athletes.
Get free science updates with Science X Daily and Weekly Newsletters — subscribe now to customize your preferences!
"Carrying a broken AMPD1 enzyme, the likelihood of reaching athletic performance is reduced by half," Macak adds.
In summary, although AMPD1 activity appears to have only moderate relevance in contemporary Western societies, it is important under extreme physical conditions, such as those experienced by athletes. The researchers emphasize the importance of studying genetic variants in their physiological and evolutionary contexts in order to understand their biological effects.
"It's possible that cultural and technological advances in both modern humans and Neanderthals reduced the need for extreme muscle performance," says senior author Hugo Zeberg.
Understanding how ancient gene variants affect human physiology today can provide valuable insights into health, performance, and genetic diversity.
Neanderthal gene variant lowers muscle enzyme activity in modern humans
The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.
phys.org
